ATTR Amyloidosis Treatment Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

ATTR Amyloidosis Treatment Market is segmented By Type (Hereditary ATTR Amyloidosis, Wild-type ATTR Amyloidosis), By Treatment (Pharmacological Therapies, Organ Transplantation, Supportive Care), By Route of Administration(Oral, Intravenous, Subcutaneous), By End User (Hospitals, Specialty Clinics, Homecare Settings), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

ATTR Amyloidosis Treatment Market Leaders

  • Pfizer Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Eidos Therapeutics, Inc.
  • Akcea Therapeutics, Inc.
*Disclaimer: Major players are listed in no particular order.

ATTR Amyloidosis Treatment Market - Company List

  • Pfizer Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Eidos Therapeutics, Inc.
  • Akcea Therapeutics, Inc.
  • Prothena Corporation plc
  • Corino Therapeutics, Inc.
  • AstraZeneca plc

ATTR Amyloidosis Treatment Market Report Snapshots

Buy Now